Getz Pharma organized the Metabolic Health Forum at its Astola Facility, bringing together more than 1,200+ leading HCPs, including leading endocrinologists of Pakistan, and healthcare professionals for an engaging scientific discussion on understanding GLP-1 therapy in everyday clinical practice.

The forum served as a platform for evidence-based learning and professional collaboration, focusing on key developments in the management of diabetes and obesity. Through a series of expert-led discussions and interactive sessions, participants explored practical approaches to treatment optimization, patient-centered care, and the effective integration of GLP-1 therapies into metabolic health management.

Designed to encourage knowledge sharing and clinical dialogue, the event highlighted the importance of translating scientific evidence into real-world practice. National experts shared insights on addressing common treatment challenges, improving adherence, and supporting better outcomes for patients living with metabolic disorders.

The forum also provided opportunities for networking and professional engagement, enabling healthcare professionals from diverse specialties to exchange experiences and perspectives on the future of metabolic care in Pakistan.

Adding a unique dimension to the program, the event featured an educational theatrical performance that reflected the patient journey through diagnosis, treatment, and disease management. The presentation offered a human-centered perspective on metabolic health while reinforcing the value of early intervention, informed decision-making, and timely action in improving long-term outcomes.

Through initiatives such as the Metabolic Health Forum, Getz Pharma continues to support scientific advancement, clinical education, and meaningful dialogue within the healthcare community, contributing to the ongoing effort to enhance metabolic care and improve patient outcomes across Pakistan.